ArticleClinical lymphoma, myeloma & leukemia2018

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.

Julie E Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.